default author photo

Matthieu Carton

PSL Research University - Institut Curie

Paris, CNRS UMR32

France

SCHOLARLY PAPERS

3

DOWNLOADS

179

TOTAL CITATIONS

0

Scholarly Papers (3)

Potential Benefit of New Target Inhibitors in Neurotrophic Tropomyosin Receptor Kinase Fusion Positive Tumors: A Historical Cohort Analysis

Number of pages: 28 Posted: 14 Apr 2022
PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Clocheville Hospital - Pediatric Onco-Hematology Service, Aix-Marseille University - Assistance Publique-Hopitaux de Marseille, Gustave Roussy, Hospital Sant Joan de Deu - Department of Pediatric Hematology and Oncology, Université d'Amiens - Department of Oncology-Hematology and Pediatric Immunology, University of Strasbourg - Department of Hematology and Oncology, Hospital Sant Joan de Deu - Department of Pediatric Hematology and Oncology, University of Lille II - Centre Oscar Lambret, PSL Research University - Institut Curie, Gustave Roussy, University of Claude Bernard Lyon 1 - Centre Léon Bérard, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie and PSL Research University - SIREDO Oncology Center
Downloads 53 (1,049,673)

Abstract:

Loading...

Neurotrophic Tropomyosin Receptor Kinase, Fusion Transcript Tumor, TRK Inhibitor, Infantile Fibrosarcoma, burden of therapy.

Potential Benefit of New Target Inhibitors in Neurotrophic Tropomyosin Receptor Kinase Fusion Positive Tumors: A Historical Cohort Analysis

Number of pages: 20 Posted: 10 May 2022
PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Clocheville Hospital - Pediatric Onco-Hematology Service, Aix-Marseille University - Assistance Publique-Hopitaux de Marseille, Gustave Roussy, Hospital Sant Joan de Deu - Department of Pediatric Hematology and Oncology, Université d'Amiens - Department of Oncology-Hematology and Pediatric Immunology, University of Strasbourg - Department of Hematology and Oncology, Hospital Sant Joan de Deu - Department of Pediatric Hematology and Oncology, University of Lille II - Centre Oscar Lambret, PSL Research University - Institut Curie, Gustave Roussy, University of Claude Bernard Lyon 1 - Centre Léon Bérard, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie and PSL Research University - SIREDO Oncology Center
Downloads 42 (1,183,247)

Abstract:

Loading...

Neurotrophic Tropomyosin Receptor Kinase, Fusion Transcript Tumor, TRK Inhibitor, Infantile Fibrosarcoma, burden of therapy.

2.

Lung cancer epidemiology in France: rising the Epidemiological Strategy and Medical Economics (ESME) Lung Cancer database Lung cancer in France

Number of pages: 32 Posted: 09 Mar 2026
PSL Research University - Institut Curie, PSL Research University - Institut Curie, UNICANCER, affiliation not provided to SSRN, affiliation not provided to SSRN, CHITS Sainte Musse, CHU Rennes, Institut Claudius Regaud, affiliation not provided to SSRN, Institut de cancérologie Strasbourg Europe ICANS, Gustave Roussy, University of Angers - CHU Angers, UNICANCER, UNICANCER, Centre Hospitalier Intercommunal de Créteil and University of Claude Bernard Lyon 1 - Centre Léon Bérard
Downloads 45 (1,157,785)

Abstract:

Loading...

Real-world data, real-life, patient medical record, quality control, Lung cancer

3.

Palliative Care Integration and End-of-Life Care Intensity for Patients with Nsclc

Number of pages: 16 Posted: 11 Jan 2024
PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Institut Curie - Department of Drug Development and Innovation (D3i), PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 39 (1,196,171)

Abstract:

Loading...

metastatic non-small cell lung cancer, end-of-life care, palliative care, systemic cancer treatment discontinuation